BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//QNADA - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:QNADA
X-ORIGINAL-URL:https://qnada.org.au
X-WR-CALDESC:Events for QNADA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Brisbane
BEGIN:STANDARD
TZOFFSETFROM:+1000
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Brisbane:20260730T130000
DTEND;TZID=Australia/Brisbane:20260730T143000
DTSTAMP:20260714T021821Z
CREATED:20260714T014901Z
LAST-MODIFIED:20260714T021821Z
UID:5781-1785416400-1785421800@qnada.org.au
SUMMARY:Harm Reduction:  the link between Australia’s new Hepatitis Strategies and the upcoming new National Drug Strategy (Online Event)
DESCRIPTION:This event will feature presentations from: \n\nRebecca Lang\, Chair\, AADC and CEO\, QNADA – Why Harm Reduction is currently the most undervalued pillar of Australia’s National Drug Strategy\nLucy Clynes\, CEO\, Hepatitis Australia – The new National Hepatitis Strategies – Priority Populations and Settings\nEle Morrison\, Deputy CEO\, AIVL – How the harm reduction work of AIVL and its member organisations connects the priorities of the National Hepatitis and Drug Strategies\nJohn Ryan\, CEO\, Penington Institute – Overview of Penington’s Annual Overdose snapshot and policy implications\nPaul Dessauer\, CEO\, Peer Based Harm Reduction WA – Peer Based Harm Reduction WA: Case study of the scope of harm reduction work undertaken by peer-based drug user organisations.\n\nPlus a panel session and audience Q&A responding to the presentations and elaborating on the event topic. \nRegister here. \n 
URL:https://qnada.org.au/event/harm-reduction-the-link-between-australias-new-hepatitis-strategies-and-the-upcoming-new-national-drug-strategy-online-event/
END:VEVENT
END:VCALENDAR